# C1-inhibitor in Allergic ASThma Patients

> **NCT03051698** · PHASE4 · TERMINATED · sponsor: **T. van der Poll** · enrollment: 37 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** C1-inhibitor
- **OTHER:** Saline
- **DRUG:** Antibiotics

## Key facts

- **NCT ID:** NCT03051698
- **Lead sponsor:** T. van der Poll
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11-16
- **Primary completion:** 2019-10-23
- **Final completion:** 2019-10-23
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Interim analysis showed no differences between groups
- **Last updated:** 2020-06-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03051698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03051698, "C1-inhibitor in Allergic ASThma Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03051698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*